Prothena | PRTA - Equity Capital And Reserves

Stock Price
10.32
Daily Change
0.28 2.79%
Monthly
5.20%
Yearly
-1.53%
Q2 Forecast
9.55

Prothena reported $280.47M in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Acadia Pharmaceuticals USD 917.27M 94.89M Sep/2025
Agios Pharmaceuticals USD 1.19B 91.22M Dec/2025
Akebia Therapeutics USD 32.61M 8.98M Dec/2025
ALKERMES USD 1.82B 85.86M Dec/2025
Alnylam Pharmaceuticals USD 789.18M 555.28M Dec/2025
Amgen USD 8.66B 961M Dec/2025
Biogen USD 18.21B 573.5M Sep/2025
BioMarin Pharmaceutical USD 6.09B 30.29M Dec/2025
Exelixis USD 2.16B 619K Dec/2025
Immunic USD 10.5M 23.41M Sep/2025
Incyte USD 5.17B 516.28M Dec/2025
Ionis Pharmaceuticals USD 617.97M 13.76M Sep/2025
MacroGenics USD 55.59M 11.41M Dec/2025
Nektar Therapeutics USD 89.83M 4.75M Dec/2025
Neurocrine Biosciences USD 3.25B 249.5M Dec/2025
Prothena USD 280.47M 14.51M Dec/2025
Regeneron Pharmaceuticals USD 31.26B 299.1M Dec/2025
Ultragenyx Pharmaceutical USD 9.16M 142.13M Sep/2025
Vertex Pharmaceuticals USD 18.67B 1.35B Dec/2025
Xoma USD 87.94M 15.5M Sep/2025